Levy Howard 4
4 · CATALYST BIOSCIENCES, INC. · Filed Nov 16, 2018
Insider Transaction Report
Form 4
Levy Howard
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2018-11-16$4.63/sh+173$801→ 7,733 total - Sale
Common Stock
2018-11-16$11.00/sh−173$1,903→ 7,560 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-11-16−173→ 87,267 totalExercise: $4.63Exp: 2027-07-11→ Common Stock (173 underlying)
Footnotes (2)
- [F1]Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on September 5, 2018.
- [F2]The Option vests monthly over a period of four years commencing June 15, 2017.